In Re RIGGS
Federal Circuit: Off-label drug use methods not patentable under § 101
In Re RIGGS, decided by Federal Circuit on March 24, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient with a "disease or condition" usi...